Loading...
•
Jun 30, 2023
Enovis Q2 2023 Earnings Report
Enovis' Q2 2023 results demonstrated strong momentum with sales growth and EBITDA margin expansion.
Key Takeaways
Enovis reported strong second-quarter results with 8% sales growth and significant EBITDA margin expansion. The reconstructive segment grew by 18%, and the prevention and recovery segment grew by 4%. The company has raised its full-year outlook for revenue and adjusted EPS.
Second quarter sales grew by 8% with strong EBITDA margin expansion.
Reconstructive segment experienced organic growth of 17%.
Prevention and Recovery segment grew by 4% organically.
Net loss from continuing operations was $0.27 per share, with adjusted EPS of $0.61.
Enovis
Enovis
Forward Guidance
Enovis updated its financial expectations for 2023.
Positive Outlook
- Revenue is expected to organically grow 7-7.5% from the prior year versus prior expectations of 6-7% growth.
- Adjusted EBITDA is forecasted to be $262-$270 million as compared with the previous outlook of $259-$267 million.
- Full-year adjusted earnings per diluted share guidance from $2.18-$2.32 to $2.22-$2.36.